Abstract
To the Editor:— The significance of ascending urinary tract infection as a cause of pyelonephritis is well recognized, thus prevention by correcting possible urinary tract abnormalities becomes of paramount importance. Apart from surgical correction of anatomical and functional abnormalities, which often is fundamental toward successful eradication of infection, the proper selection and application of antibacterial therapy can be a challenge. This is particularly true if severe chronic renal disease already is present. If bacterial cultures of urine from such patients indicate sensitivity of the offending organism to the more commonly used antibacterial agents such as sulfonamides, nitrofurantoin, and nalidixic acid for long term administration, standard therapeutic dosages often give disappointing results. Only too often the uremic patient with bacteriuria remains infected and the infecting organism becomes resistant to the drug administered. It is further a dilemma for the treating physician that dose recommendation of drugs for treatment of bacteriuria are
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
More From: JAMA: The Journal of the American Medical Association
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.